1. Home
  2. Bills
  3. H.R. 639

H.R. 639 · 114th Congress · 2015–2016

Improving Regulatory Transparency for New Medical Therapies Act

H.R. 639 in the 114th Congress (2015–2016) became law — introduced on Feb 2, 2015, sponsored by Joseph R. Pitts with 3 co-sponsors.

During the 114th Congress (2015–2016), Barack Obama was president, and Republicans held majorities in both the House and Senate.

Status
Became law
Introduced
Feb 2, 2015
Co-sponsors
3
Policy area
Crime and Law Enforcement
Public law
Public Law 114-89

What it does

Improving Regulatory Transparency for New Medical Therapies Act (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the…

Summary by the nonpartisan Congressional Research Service.

Sponsor

Joseph R. Pitts (R-PA). Co-sponsors: 2 Democrats, 1 Republican.

Where it stands

  • IntroducedFeb 2, 2015
  • Passed the HouseMar 16, 2015
  • Passed the SenateOct 26, 2015
  • Sent to the PresidentNov 19, 2015
  • Became lawNov 25, 2015

Latest action: Became Public Law No: 114-89. (Nov 25, 2015)

Other Crime and Law Enforcement bills in the 114th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 639 (114th Congress): Improving Regulatory Transparency for New…,” https://www.capitolreceipts.com/bill/114-hr-639/improving-regulatory-transparency-for-new-medical-therapies-act (accessed 2026-10-17).